CN1064258C - 三七提取物软胶囊及其制备工艺 - Google Patents
三七提取物软胶囊及其制备工艺 Download PDFInfo
- Publication number
- CN1064258C CN1064258C CN98106596A CN98106596A CN1064258C CN 1064258 C CN1064258 C CN 1064258C CN 98106596 A CN98106596 A CN 98106596A CN 98106596 A CN98106596 A CN 98106596A CN 1064258 C CN1064258 C CN 1064258C
- Authority
- CN
- China
- Prior art keywords
- soft capsule
- gelatin
- extract
- lecithin
- glycerol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000007901 soft capsule Substances 0.000 title claims abstract description 25
- 235000003143 Panax notoginseng Nutrition 0.000 title claims abstract description 20
- 241000180649 Panax notoginseng Species 0.000 title claims abstract description 20
- 238000000034 method Methods 0.000 title description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 59
- 229920000159 gelatin Polymers 0.000 claims abstract description 27
- 235000019322 gelatine Nutrition 0.000 claims abstract description 27
- 108010010803 Gelatin Proteins 0.000 claims abstract description 26
- 239000008273 gelatin Substances 0.000 claims abstract description 26
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 26
- 238000003756 stirring Methods 0.000 claims abstract description 12
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 11
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 11
- 239000000787 lecithin Substances 0.000 claims abstract description 11
- 229940067606 lecithin Drugs 0.000 claims abstract description 11
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 10
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 10
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 10
- 235000010445 lecithin Nutrition 0.000 claims abstract description 10
- 238000002360 preparation method Methods 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000002904 solvent Substances 0.000 claims abstract description 3
- 235000011187 glycerol Nutrition 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 15
- 235000006708 antioxidants Nutrition 0.000 claims description 10
- 239000003085 diluting agent Substances 0.000 claims description 7
- 239000000375 suspending agent Substances 0.000 claims description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 238000005516 engineering process Methods 0.000 claims description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 4
- 238000007872 degassing Methods 0.000 claims description 4
- -1 dibenzylatiooluene Chemical compound 0.000 claims description 4
- 239000004615 ingredient Substances 0.000 claims description 4
- 210000000582 semen Anatomy 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 4
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims description 2
- LKAPTZKZHMOIRE-KVTDHHQDSA-N (2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolane-2-carbaldehyde Chemical compound OC[C@H]1O[C@H](C=O)[C@@H](O)[C@@H]1O LKAPTZKZHMOIRE-KVTDHHQDSA-N 0.000 claims description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 2
- 229920001817 Agar Polymers 0.000 claims description 2
- 229920002101 Chitin Polymers 0.000 claims description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 2
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 2
- 229920000896 Ethulose Polymers 0.000 claims description 2
- 239000001856 Ethyl cellulose Substances 0.000 claims description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 2
- 239000001859 Ethyl hydroxyethyl cellulose Substances 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 2
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 claims description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 2
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 claims description 2
- 240000008415 Lactuca sativa Species 0.000 claims description 2
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 claims description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- 239000008272 agar Substances 0.000 claims description 2
- 235000010419 agar Nutrition 0.000 claims description 2
- 229940087168 alpha tocopherol Drugs 0.000 claims description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 2
- 235000010323 ascorbic acid Nutrition 0.000 claims description 2
- 239000011668 ascorbic acid Substances 0.000 claims description 2
- 229960005070 ascorbic acid Drugs 0.000 claims description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 2
- 239000007766 cera flava Substances 0.000 claims description 2
- LKAPTZKZHMOIRE-UHFFFAOYSA-N chitose Natural products OCC1OC(C=O)C(O)C1O LKAPTZKZHMOIRE-UHFFFAOYSA-N 0.000 claims description 2
- 229960004106 citric acid Drugs 0.000 claims description 2
- 235000015165 citric acid Nutrition 0.000 claims description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 2
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 2
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 2
- 229920001249 ethyl cellulose Polymers 0.000 claims description 2
- 235000019326 ethyl hydroxyethyl cellulose Nutrition 0.000 claims description 2
- 229960002449 glycine Drugs 0.000 claims description 2
- 150000002333 glycines Chemical class 0.000 claims description 2
- 229960004337 hydroquinone Drugs 0.000 claims description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 2
- 229940071826 hydroxyethyl cellulose Drugs 0.000 claims description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 2
- 229960000367 inositol Drugs 0.000 claims description 2
- 239000001630 malic acid Substances 0.000 claims description 2
- 235000011090 malic acid Nutrition 0.000 claims description 2
- 229940099690 malic acid Drugs 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 229920000609 methyl cellulose Polymers 0.000 claims description 2
- 239000001923 methylcellulose Substances 0.000 claims description 2
- 235000010981 methylcellulose Nutrition 0.000 claims description 2
- 239000000467 phytic acid Substances 0.000 claims description 2
- 235000002949 phytic acid Nutrition 0.000 claims description 2
- 229940068041 phytic acid Drugs 0.000 claims description 2
- RWPGFSMJFRPDDP-UHFFFAOYSA-L potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 claims description 2
- 229940043349 potassium metabisulfite Drugs 0.000 claims description 2
- 235000010263 potassium metabisulphite Nutrition 0.000 claims description 2
- 235000012045 salad Nutrition 0.000 claims description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 2
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims description 2
- 235000010378 sodium ascorbate Nutrition 0.000 claims description 2
- 229960005055 sodium ascorbate Drugs 0.000 claims description 2
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 claims description 2
- 235000010262 sodium metabisulphite Nutrition 0.000 claims description 2
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 claims description 2
- 229960000984 tocofersolan Drugs 0.000 claims description 2
- 239000000230 xanthan gum Substances 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- 235000010493 xanthan gum Nutrition 0.000 claims description 2
- 229940082509 xanthan gum Drugs 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- 239000002076 α-tocopherol Substances 0.000 claims description 2
- 235000004835 α-tocopherol Nutrition 0.000 claims description 2
- 239000001828 Gelatine Substances 0.000 claims 1
- 235000013305 food Nutrition 0.000 abstract description 7
- 238000002156 mixing Methods 0.000 abstract description 2
- 239000002775 capsule Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000003825 pressing Methods 0.000 abstract 1
- 238000009849 vacuum degassing Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 description 6
- 235000015112 vegetable and seed oil Nutrition 0.000 description 6
- 239000008158 vegetable oil Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000007903 gelatin capsule Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000132521 Erigeron Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000010687 lubricating oil Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012372 quality testing Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011265 semifinished product Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
本发明为软胶囊剂口服保健食品及制备工艺。每粒产品中含三七提取物10-400毫克，并含有卵磷脂和食用辅料。囊壳中含有明胶10份，甘油3.25-3.35份(重量比)，制备工艺：明胶加适量水完全溶解后加入甘油，搅拌均匀，抽真空脱气后保温静置待用；三七提取物与溶剂相混合后再加入抗氧剂等，搅拌均匀，室温静置；用模具压软胶囊。本发明提供了以三七提取物为主要有效成分的软胶囊保健(功能)食品，食用和携带便利，保健功能强。
Description
本发明涉及含有三七提取物有效剂量的软胶囊剂口服保健(功能)食品及其制备工艺。
三七提取物为黄色粉末，可溶于甲醇、乙醇、水，不溶于乙醚等。具有较明显的调节血脂和免疫调节作用。试验证明：对免疫功能失调及血脂失调的人群有较好的辅助治疗作用。也无毒副作用。
目前，市场上尚未有以三七提取物为主要有效成分的保健(功能)食品，更无相应的软胶囊的食品。
本发明的目的是提供一种三七提取物软胶囊及其制备工艺，产品为保健(功能)食品，其质量稳定，使用方便、有效。
-本发明产品由保健液和囊壳两大部分构成，保健液含有效剂量的三七提取物作为有效成分，并含有食用辅料，其特征是食用辅料包括稀释剂、抗氧剂、助悬剂，囊壳中含有明胶10份，甘油3．25-3．35份(重量比)，保健液按重量每粒含有三七提取物10-400毫克，并还含有卵磷脂。
稀释剂可以是花生油、玉米油、豆油、茶油、色拉油中的一种或几种。
抗氧剂可以是乙二胺四乙酸、乙二胺四乙酸二钠盐、二丁基羟基甲苯、D-木糖、木糖醇、甘氨酸、α-生育酚、α-醋酸生育酚、肌醇、抗坏血酸、抗坏血酸钠、卵磷脂、苹果酸、氢醌、枸橼酸、琥珀酸、植酸、焦亚硫酸钠、焦亚硫酸钾中的一种或几种。
助悬剂可以是乙基羟乙基纤维素、甲壳素、卵磷脂、甲壳糖、甲基纤维素、乙基纤维素、琼脂、黄原胶、羟乙基甲基纤维素、羟乙基纤维素、羟丙基甲基纤维素、羟丙基纤维素、蜂蜡等中的一种或几种。
在研究三七提取物软胶囊的过程中，解决了以下主要难题：
1、囊壳配方(适用于油溶性保健液)
囊壳的配方中明胶、甘油配比难以掌握。甘油的量太多，囊壳较软，比较容易受挤压变形；甘油的量太少，囊壳较硬、脆，影响软胶囊的质量稳定性及崩解时间。我们对囊壳的明胶、甘油的配比进行了详细的试验研究，最后获得了一个较好的配比。
将适量明胶加入不锈钢溶胶罐中，再加入适量水，密闭，70℃保温3小时，再分别加入试验用量的甘油、防腐剂，搅拌，抽真空脱气2小时，放入明胶保温桶中70℃保温静置过夜，第二天，压胶丸，室温干燥，留样考察三个月，考查囊壳外观和物理性能，结果如下：
| 指标／试验内容 | 明胶10kg甘油3.0kg | 明胶10kg甘油3.2kg | 明胶10kg甘油3.25-3.35kg | 明胶10kg甘油3.4kg | 明胶10kg甘油3.6kg |
| 囊壳外观及物理性能 | 太硬、易脆 | 太硬、易脆 | 合适 | 较软、易潮 | 较软、易吸潮 |
说明：所筛选出的囊壳配方适用于温暖潮湿的地方。
通过以上试验，可以得出结论，囊壳的配方中应含有：明胶10份，甘油3．25-3．35份(重量比)。
2、保健液配方
软胶囊的囊壳决定了保健液所用的稀释剂不能是水、乙醇及一些毒性较大的有机溶剂，最为理想的是油脂类物质。但由于三七提取物难以溶于植物油，因此，我们通过大量的试验，选用了一种毒性较小、能够溶解于植物油中、能很好地将三七提取物悬浮于植物油中，并且能够长时间稳定的物质-卵磷脂。
将适量的卵磷脂溶解于适量的植物油中，再将三七提取物加入其中，之后加入合适的抗氧剂以防止软胶囊中的保健液在贮存过程中发生变质(氧化)，胶丸每粒含主药-三七提取物的量是确定的；考虑经济因素及制备方便选定每丸的大小，最终可确定实施例的保健液配方。
本发明产品的最佳配方中应含有：组 份 量(克／粒)三七提取物 0．01-0．5稀释剂 0．06-1．2明胶 0．04-0．5甘油 (明胶量的32．5-33．5％)卵磷脂 0．002-0．022助悬剂 0．005-0．009抗氧剂 0．0007-0．005
注：最佳配方仅为了对本发明作进一步的说明，而本发明产品的范围不受该最佳配方的局限。
三七提取物软胶囊的制备工艺包括以下步骤：
明胶在搅拌状态下加入适量水，待明胶完全溶解后，加入甘油，搅拌均匀，抽真空脱气后保温静置待用：称取三七提取物与配方量的溶剂相混合，待完全混合后再加入抗氧剂等，搅拌均匀，室温静置：
将配好的药液倒入药液斗中，用模具压软胶囊。
本发明的积极效果是提供了以三七提取物为主要有效成分的软胶囊保健(功能)食品，食用和携带便利，保健功能强。
本发明按上述方法制备，其详细组份由下列实施例给出，但本发明的保护范围不局限于此。实施例1组 份 量(克／粒)三七提取物 0．05花生油 0．22明胶 0．11甘油 0．04卵磷脂 0．007α-生育酚 0．0008实施例2组 份 量(克／粒)三七提取物 0．1豆油 0．07明胶 0．05甘油 0．015乙基羟乙基纤维素 0．005卵磷脂 0．005实施例3组 份 量(克／粒)三七提取物 0．02玉米油 0．1明胶 0．05甘油 0．017羟乙基纤维素 0．006α-醋酸生育酚 0．0008卵磷脂 0．003实施例4组 份 量(克／粒)三七提取物 0．1豆油 0．2玉米油 0．1明胶 0．12甘油 0．04卵磷脂 0．006抗坏血酸 0．0008实施例5组 份 量(克／粒)三七提取物 0．2花生油 0．4豆油 0．15明胶 0．17甘油 0．06羟丙基纤维素 0．007α-生育酚 0．0008卵磷脂 0．015实施例6组 份 量(克／粒)三七提取物 0．4色拉油 0．8茶油 0．3明胶 0．4甘油 0．14甲基纤维素 0．009α-醋酸生育酚 0．0008卵磷脂 0．020
以上实施例产品的制备工艺为：
称取明胶加入100L明胶反应罐，在搅拌状态下加入适量水，密闭，待明胶完全溶解后，再加入甘油，搅拌均匀，抽真空脱气2小时，放入明胶保温桶中，保温静置过夜，待用。
于室温下将助悬剂加入植物油中，称取三七提取物，粉碎，过筛，与植物油混合，待完全混匀后再加入抗氧剂等，搅拌均匀，室温静置。
将明胶保温桶悬挂至一定高度，配好的药液倒入漏斗中，换上模具开始压软胶囊，调整软胶囊装量至设计范围，室温干燥二天，剔除外观质量差的胶丸，将胶丸洗涤(去除压丸过程中的润滑油)，再于24℃干燥二天，得灯盏花素软胶囊半成品，质量检测合格后分装、贴签、包装，即得三七提取物软胶囊成品。
Claims (4)
1、一种三七提取物软胶囊，由保健液和囊壳两大部分构成，保健液由作为有效成分的有效剂量的三七提取物和食用辅料组成，其特征是食用辅料包括稀释剂、抗氧剂、助悬剂，囊壳由明胶10份、甘油3．25-3．35份、卵磷脂组成，所述有效剂量是10-400毫克三七提取物／粒软胶囊。
2、如权利要求1所说的三七提取物软胶囊，其特征是：
稀释剂是花生油、玉米油、豆油、茶油、色拉油中的一种或几种，
抗氧剂是乙二胺四乙酸、乙二胺四乙酸二钠盐、二丁基羟基甲苯、D-木糖、木糖醇、甘氨酸、α-生育酚、α-醋酸生育酚、肌醇、抗坏血酸、抗坏血酸钠、卵磷脂、苹果酸、氢醌、枸橼酸、琥珀酸、植酸、焦亚硫酸钠、焦亚硫酸钾中的一种或几种，
助悬剂是乙基羟乙基纤维素、甲壳素、卵磷脂、甲壳糖、甲基纤维素、乙基纤维素、琼脂、黄原胶、羟乙基甲基纤维素、羟乙基纤维素、羟丙基甲基纤维素、羟丙基纤维素、蜂蜡等中的一种或几种。
3、如权利要求2所说的三七提取物软胶囊，其特征是各组分及重量为：组 份 克／粒三七提取物 0．01-0．5稀释剂 0．06-1．2明胶 0．04-0．5甘油 明胶量的32．5-33．5％卵磷脂 0．002-0．022助悬剂 0．005-0．009抗氧剂 0．0007-0．005
4、权利要求1、2或3的三七提取物软胶囊制备工艺，其特征是包括以下步骤：
明胶在搅拌状态下加入适量水，待明胶完全溶解后，加入甘油，搅拌均匀，抽真空脱气后保温静置待用，
称取三七提取物按比例与溶剂混合，待完全混合后再加入抗氧剂等，搅拌均匀，室温静置，
将配好的药液倒入药液斗中，用模具压软胶囊。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98106596A CN1064258C (zh) | 1998-03-17 | 1998-03-17 | 三七提取物软胶囊及其制备工艺 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98106596A CN1064258C (zh) | 1998-03-17 | 1998-03-17 | 三七提取物软胶囊及其制备工艺 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1228973A CN1228973A (zh) | 1999-09-22 |
| CN1064258C true CN1064258C (zh) | 2001-04-11 |
Family
ID=5219032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN98106596A Expired - Lifetime CN1064258C (zh) | 1998-03-17 | 1998-03-17 | 三七提取物软胶囊及其制备工艺 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1064258C (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1326518C (zh) * | 2004-03-26 | 2007-07-18 | 石药集团中奇制药技术（石家庄）有限公司 | 逍遥软胶囊及其制备工艺 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1129118A (zh) * | 1995-02-15 | 1996-08-21 | 昆明制药股份有限公司 | 复方三七制剂 |
-
1998
- 1998-03-17 CN CN98106596A patent/CN1064258C/zh not_active Expired - Lifetime
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1129118A (zh) * | 1995-02-15 | 1996-08-21 | 昆明制药股份有限公司 | 复方三七制剂 |
Non-Patent Citations (1)
| Title |
|---|
| 《中药药剂学》第1版 1986.1.1 曹春霖，上海科技版 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1326518C (zh) * | 2004-03-26 | 2007-07-18 | 石药集团中奇制药技术（石家庄）有限公司 | 逍遥软胶囊及其制备工艺 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1228973A (zh) | 1999-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bolkent et al. | Effects of chard (Beta vulgaris L. var. cicla) extract on pancreatic B cells in streptozotocin-diabetic rats: a morphological and biochemical study | |
| KR101931186B1 (ko) | 목향 또는 침향을 포함하는 공진단 액제 조성물 및 그 제조방법 | |
| CN105851998A (zh) | 一种抗氧化软胶囊及其制备方法 | |
| CN102058631B (zh) | 沙棘叶提取物制剂及其制备方法 | |
| CN103652859A (zh) | 一种具有抗氧化功能的保健食品及其制备方法 | |
| CN108888601A (zh) | 一种维生素e硒微胶囊片剂、制备方法及其用途 | |
| CN113575698B (zh) | 一种鱼油软胶囊及其制备方法和应用 | |
| CN114344352A (zh) | 一种具有抗晚期糖基化终产物功效的组合物及其应用 | |
| CN1064258C (zh) | 三七提取物软胶囊及其制备工艺 | |
| CN104286336A (zh) | 一种无糖型雪菊糖及其制备方法 | |
| CN108968069A (zh) | 缓解视力疲劳、改善视力、抗氧化、保护视网膜的复合软胶囊及制备方法 | |
| CN111227251A (zh) | 一种含有沙棘籽油螺旋藻维生素e的软胶囊及其制备方法 | |
| CN106798335A (zh) | 中链甘油三酯的应用 | |
| CN101611760A (zh) | 大豆卵磷脂的提取及其系列产品的生产方法 | |
| CN86101578A (zh) | 中草药复合半透膜保鲜剂及制造方法 | |
| CN108785476A (zh) | 含有阿萨伊果和肉苁蓉的固体组合物的制备方法和应用 | |
| CN100544707C (zh) | 灵丹草软胶囊剂及其生产方法 | |
| CN102429180B (zh) | 一种食用组合物及其制备方法与应用 | |
| CN1228959A (zh) | 灯盏花素软胶囊及其生产方法 | |
| CN100496467C (zh) | 一种含有丹栀提取物的软胶囊及其制备方法 | |
| CN112957409A (zh) | 一种葡萄籽红花籽油组合物及其应用 | |
| CN106619560B (zh) | 一种多烯磷脂酰胆碱胶囊及其制备工艺 | |
| Aftergood et al. | Oral contraceptive-α-tocopherol interrelationships | |
| CN100367954C (zh) | 穿心莲内酯软胶囊制剂及其制备方法 | |
| CN103083279B (zh) | 藻酸双酯钠软胶囊 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee |
Owner name: KUNMING MEDICINE GROUP STOCK CO., LTD. Free format text: FORMER NAME OR ADDRESS: KUNMING MEDICINE STOCK CO., LTD. |
|
| CP01 | Change in the name or title of a patent holder |
Patentee after: Kunming Pharmaceutical Industry Group Corp., Ltd. Patentee before: Kunming Pharmaceutical Co., Ltd. |
|
| C56 | Change in the name or address of the patentee |
Owner name: KPC CO., LTD. Free format text: FORMER NAME: KUNMING PHARMACEUTICAL INDUSTRY GROUP CORP., LTD. |
|
| CP03 | Change of name, title or address |
Address after: 650106 Kunming science and Technology Industrial Development Zone, Yunnan Province Road No. 166 Patentee after: Kun Yao Group Plc Address before: 650100, seven kilometers west of Kunming City, Yunnan Province Patentee before: Kunming Pharmaceutical Industry Group Corp., Ltd. |
|
| CX01 | Expiry of patent term |
Granted publication date: 20010411 |
|
| CX01 | Expiry of patent term |